Chewy CFO, GC Trim Stakes After March Equity Grants
NEW YORK, May 1 —
Two of Chewy's top officers sold stock on the open market within weeks of the company handing them fresh equity grants. General Counsel Da-wai Hu and CFO Christopher Deppe were the names on the Form 4s, and the timing — selling into the same window the company was loading up the C-suite with new shares — is the kind of choreography that gets noticed.
- GC Da-wai Hu sold 8,149 shares at $26.91 on April 1 for roughly $219,000 (Form 4).
- CFO Christopher Deppe sold 3,043 shares at $26.87 on March 2 for roughly $82,000.
- The company issued large equity awards on March 25 and April 8, including 394,868 shares to CEO Sumit Singh on April 8 and 526,284 shares on March 25.
What the Form 4s Actually Say
Insider activity over the trailing 90 days nets out to about $0.30M in open-market sales against zero purchases. That is a small number in absolute dollars, but the composition matters more than the size. Hu's $219,000 sale on April 1 and Deppe's $82,000 sale on March 2 were both genuine open-market dispositions, not the cashless tax-withholding mechanics that automatically clip a few percentage points off every vesting tranche.
Those tax-withholding dispositions also showed up. CEO Sumit Singh's largest single line item in the period was a 30,267-share withholding event on February 27 priced at $26.97, valued at roughly $816,000. That kind of disposition is mechanical — when restricted stock vests, shares get withheld to cover the tax bill — and reading it as a discretionary sale would overstate the case.
The Grant-Then-Sell Pattern
What sharpens the picture is the grant calendar. On March 25, Chewy filed an 8-K reporting earnings and issued equity awards including 526,284 shares to Singh, 49,962 to Hu, 14,470 to Chief Accounting Officer William Billings, and 4,342 to Deppe. Two weeks later, a separate 8-K on April 8 coincided with another tranche: 394,868 shares to Singh, 346,670 to Deppe, 37,486 to Hu, and 32,571 to Billings.
Deppe's 3,043-share sale predates both grants, so it is not a "took the grant, sold the grant" story for him. Hu's April 1 sale, by contrast, sits squarely between the two award dates. Neither sale is large enough on its own to constitute a signal — six-figure sales by named executive officers happen routinely under 10b5-1 plans. The point is directional: the people closest to the books are taking some chips off, not adding to them.
The Counter-Argument the Numbers Make
The bear read on insider behavior runs into a fundamentals problem. Chewy generated $453M in free cash flow on $12.6B of trailing revenue, a 29.8% gross margin, and a forward P/E of 12.9x. Earnings have come in ahead of consensus in each of the last three reported quarters: $0.35 versus $0.34, $0.33 versus $0.33, and $0.32 versus $0.30. That is not the cadence of a company missing the plot.
The street's $40.81 average price target against the current $25.42 print implies roughly 60% upside if analysts are right. Whether they are right is a different question — and one Chewy's modest 0.5% revenue growth makes harder to answer. A pet-retail business that grew at half a percent year over year is either reaching saturation or absorbing a customer-acquisition reset. The forward multiple suggests the market has priced in the cautious view.
What Comes Next
Chewy filed another 8-K on April 28 under Item 7.01 — a Regulation FD disclosure, which typically signals an investor event or selectively disclosed material that needs broadcasting. That filing is worth reading on its own terms. A separate MarketBeat report flagged the Teachers Retirement System of the State of Kentucky reducing its CHWY position, per filings two days old, which is a single data point but consistent with the soft-selling backdrop.
The neutral case here is straightforward. Free cash flow generation, consistent EPS beats, and a sub-13x forward multiple keep the floor from caving in. Insider selling by the GC and CFO, paired with anemic top-line growth, keeps a ceiling on enthusiasm. The next earnings release is the natural checkpoint — if revenue growth ticks back into the mid-single digits while margins hold, the analyst targets start looking less like a stretch. If growth stays at half a percent, the insiders' pacing will look prescient.
Run the free Chewy, Inc. deep-dive →
Basis Report does not hold positions in securities discussed. This is not investment advice.
Frequently Asked Questions
Are Chewy insiders selling stock?
Yes, on a small scale. Over the past 90 days, the General Counsel and CFO executed open-market sales totaling roughly $0.30M against zero purchases, as detailed in the filing analysis above.
Why did Chewy's CFO sell shares?
The Form 4 doesn't state a reason. The 3,043-share sale on March 2 followed equity grants, a common pattern for officers diversifying after vesting, as discussed in this report.
What is Chewy's analyst price target?
The average sell-side target is $40.81, against a current price of $25.42, implying material upside if the company executes on the fundamentals reviewed above.
Is Chewy stock cheap right now?
At a forward P/E of 12.9x with $453M in free cash flow, the multiple is undemanding, but trailing revenue growth of 0.5% complicates the bull case, as the analysis above explains.
When does Chewy report earnings next?
Chewy's most recent earnings 8-K was filed March 25, 2026. The next quarterly release is the catalyst that will test the neutral thesis laid out in this report.